Abbott India
Abbott gets DCGI nod for once-a-day heart failure, angina treatment drug
Nifty may resume downtrend if it breaks below 11,350: HDFC Securities
Abbott India: More branded products, new launches, volumes to aid gains
11,250 crucial for Nifty to negate bearish set-up: Vinay Rajani of HDFC Sec
Indices gain for 2nd day in a row, Sensex up 429 pts; India VIX drops 6%

Abbott India, Pfizer, L&T Infotech: 11 stocks that may enter F&O segment
New launches could spur growth at Abbott India, near-term headwinds weigh
Near-term hiccups to have limited impact on Abbott India's growth: Experts
Abbott India reports 1.96% decline in Q4 net profit to Rs 110.97 crore
Abbott India up 19% as parent firm gets US FDA nod for rapid COVID-19 test

Abbott India Q2 net up 30% at Rs 178 crore, total income rises 8%
Abbott India hits all-time high, surges 35% in two months
Healthy sales in branded portfolio lift Abbott India's margins in Q1
Nestle, Abbott India, Asian Paints, Pidilite hit new highs on good earnings
Abbott India Q3 net up marginally at Rs 117 cr, revenue rises to Rs 947 cr
Abbott India ups vaccines play, to launch products in infant segment
Abbott looks beyond product portfolio to generate trust and recall
Abbott excels on power of brands, outpaces MNC peers on sales growth
Abbott India Q2 net surges 83% at Rs 138 cr on robust sales
Abbott India soars 20% on strong Q2 results